By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Xenomics Inc. 

420 Lexington Avenue, Suite 1701

New York  New York  10170  U.S.A.
Phone: 212-729-9216 Fax: 212-297-0020



Company News
Xenomics Inc. (XNOM)'s Preliminary Investigation Leads the Company to Believe Sequenom Inc. (SQNM) Willfully Manipulated its Down Syndrome Data in its Presentations 12/17/2009 10:41:20 AM
Xenomics Inc. (XNOM) and its Subsidiary TrovaGene, Inc., Announce Italian Patent for NPM1 Testing for AML Patients 12/15/2009 11:51:14 AM
Xenomics Inc. (XNOM) Files Suit Against Sequenom Inc. (SQNM) (JOBS) for Fraud 10/29/2009 6:19:04 AM
Xenomics Inc. (XNOM) Appoints Bruce A. Huebner as Chief Executive Officer and Board Member 10/6/2009 6:39:45 AM
Xenomics Inc. (XNOM) Presents New Diagnostics Platform: Detection of In Vivo Cell Death by Analysis of Cell-Free Tissue-Specific miRNA in Urine or Blood 3/23/2009 9:02:04 AM
Xenomics Inc. (XNOM) Provides Update on NPM1 Testing for AML 2/24/2009 10:24:21 AM
Editorial Article in the Clinical Chemistry Highlights Significant Progress in Optimization of the Non-Invasive Transrenal DNA Technology Reported by Xenomics Inc. (XNOM) 2/23/2009 10:03:12 AM
Xenomics Inc. (XNOM) Offers New Gender Prediction Test to Expectant Mothers 2/17/2009 12:42:30 PM
Xenomics Inc. (XNOM) Transrenal Technology Shows Significant Promise in Molecular Diagnostic Applications 2/4/2009 2:35:49 PM
Xenomics Inc. (XNOM) Discusses HPV Screening Test Based on Transrenal DNA Technology at 52nd All India Congress of Obstetrics & Gynecology 1/6/2009 11:40:04 AM